Adverse Events Associated with Sodium-Glucose Co-transporter-2 Inhibitors: A UK National Pharmacovigilance Study von Hassan, Ahmed, Ryan, David, Scourfield, Andrew

Volltext

Genetic Determinants of Idiopathic Noncirrhotic Portal Hypertension in HIV-Infected Patients von Vispo, Eugenia, Cevik, Muge, Rockstroh, Juergen K., Barreiro, Pablo, Nelson, Mark, Scourfield, Andrew, Boesecke, Christoph, Wasmuth, Jan-Christian, Soriano, Vincent

Volltext

The Evolution of Coreceptor Tropism in HIV-infected Patients Interrupting Suppressive Antiretroviral Therapy von Waters, Laura J., Scourfield, Andrew T., Marcano, Marie, Gazzard, Brian G., Bower, Mark, Nelson, Mark, Stebbing, Justin

Volltext

Artificial intelligence and machine learning for clinical pharmacology von Ryan, David K., Maclean, Rory H., Balston, Alfred, Scourfield, Andrew, Shah, Anoop D., Ross, Jack

Volltext

Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals von Cevik, Muge, Singh, Gurmit, Dickinson, Laura, Scourfield, Andrew, Boffito, Marta, Nelson, Mark

Volltext

Effectiveness of biosimilar adoption within a UK tertiary hospital: 6‐year follow‐up von Barron, Andrew, Chung, Jennifer, Ferner, Robin E., Leandro, Maria, Maru, Saloni, Scourfield, Andrew, Urquhart, Robert, Sofat, Reecha

Volltext

The impact of the COVID-19 pandemic on cardiovascular disease prevention and management von Dale, Caroline E., Takhar, Rohan, Carragher, Raymond, Katsoulis, Michail, Torabi, Fatemeh, Duffield, Stephen, Kent, Seamus, Mueller, Tanja, Kurdi, Amanj, Le Anh, Thu Nguyen, McTaggart, Stuart, Abbasizanjani, Hoda, Hollings, Sam, Scourfield, Andrew, Lyons, Ronan A., Griffiths, Rowena, Lyons, Jane, Davies, Gareth, Harris, Daniel, Handy, Alex, Mizani, Mehrdad A., Tomlinson, Christopher, Thygesen, Johan H., Ashworth, Mark, Denaxas, Spiros, Banerjee, Amitava, Sterne, Jonathan A. C., Brown, Paul, Bullard, Ian, Priedon, Rouven, Mamas, Mamas A., Slee, Ann, Lorgelly, Paula, Pirmohamed, Munir, Khunti, Kamlesh, Morris, Andrew D., Sudlow, Cathie, Akbari, Ashley, Bennie, Marion, Sattar, Naveed, Sofat, Reecha

Volltext

High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre von Abdolrasouli, Alireza, Scourfield, Andrew, Rhodes, Johanna, Shah, Anand, Elborn, J. Stuart, Fisher, Matthew C., Schelenz, Silke, Armstrong-James, Darius

Volltext

How to assess pharmacogenomic tests for implementation in the NHS in England von Sanghvi, Sonali, Ferner, Robin E., Scourfield, Andrew, Urquhart, Robert, Amin, Sejal, Hingorani, Aroon D., Sofat, Reecha

Volltext

Discontinuation of Atripla as first-line therapy in HIV-1 infected individuals von SCOURFIELD, Andrew, JIEXIN ZHENG, CHINTHAPALLI, Suchitra, WATERS, Laura, MARTIN, Thomas, MANDALIA, Sundhiya, NELSON, Mark

Volltext

The future of clinical pharmacology in the NHS von Walker, Lauren, Bennett, Frances, Scourfield, Andrew, Payne, Rupert

Volltext

Effectiveness of biosimilar adoption within a UK tertiary hospital; six-years follow up von Barron, Andrew, Chung, Jennifer, Ferner, Robin E, Leandro, Maria, Maru, Saloni, Scourfield, Andrew, Urquhart, Robert, Sofat, Reecha

Volltext

The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy von Magavern, Emma Forton, Kaski, Juan Carlos, Turner, Richard M, Drexel, Heinz, Janmohamed, Azara, Scourfield, Andrew, Burrage, Daniel, Floyd, Christopher N, Adeyeye, Elizabeth, Tamargo, Juan, Lewis, Basil S, Kjeldsen, Keld Per, Niessner, Alexander, Wassmann, Sven, Sulzgruber, Patrick, Borry, Pascal, Agewall, Stefan, Semb, Anne Grete, Savarese, Gianluigi, Pirmohamed, Munir, Caulfield, Mark J

Volltext

Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc von Armstrong-James, Darius, Stebbing, Justin, Scourfield, Andrew, Smit, Erasmus, Ferns, Bridget, Pillay, Deenan, Nelson, Mark

Volltext

Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy von Magavern, Emma F, Kaski, Juan Carlos, Turner, Richard M, Drexel, Heinz, Janmohamed, Azara, Scourfield, Andrew, Burrage, Daniel, Floyd, Christopher N, Adeyeye, Elizabeth, Tamargo, Juan, Lewis, Basil S, Kjeldsen, Keld Per, Niessner, Alexander, Wassmann, Sven, Sulzgruber, Patrick, Borry, Pascal, Agewall, Stefan, Semb, Anne Grete, Savarese, Gianluigi, Pirmohamed, Munir, Caulfield, Mark J

Volltext

Thyroid Dysfunction and Relationship to Antiretroviral Therapy in HIV-Positive Individuals in the HAART Era von Nelson, Mark, Powles, Tom, Zeitlin, Abigail, Sen, Priya, Scourfield, Andrew, Bower, Mark, Gazzard, Brian, Stebbing, Justin

Volltext

The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy von Magavern, Emma Forton, Kaski, Juan Carlos, Turner, Richard M, Drexel, Heinz, Janmohamed, Azara, Scourfield, Andrew, Burrage, Daniel, Floyd, Christopher N, Adeyeye, Elizabeth, Tamargo, Juan, Lewis, Basil S, Kjeldsen, Keld Per, Niessner, Alexander, Wassmann, Sven, Sulzgruber, Patrick, Borry, Pascal, Agewall, Stefan, Semb, Anne Grete, Savarese, Gianluigi, Pirmohamed, Munir, Caulfield, Mark J

Volltext

The value of screening HIV-infected individuals for didanosine-related liver disease? von SCOURFIELD, Andrew, JACKSON, Akil, WATERS, Laura, GAZZARD, Brian, NELSON, Mark

Volltext

Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy von Magavern, Emma F, Kaski, Juan Carlos, Turner, Richard M, Drexel, Heinz, Janmohamed, Azara, Scourfield, Andrew, Burrage, Daniel, Floyd, Christopher N, Adeyeye, Elizabeth, Tamargo, Juan, Lewis, Basil S, Kjeldsen, Keld Per, Niessner, Alexander, Wassmann, Sven, Sulzgruber, Patrick, Borry, Pascal, Agewall, Stefan, Semb, Anne Grete, Savarese, Gianluigi, Pirmohamed, Munir, Caulfield, Mark J

Volltext

Synthetic cannabinoid availability on darknet drug markets-changes during 2016-2017 von Scourfield, Andrew, Flick, Catherine, Ross, Jack, Wood, David M., Thurtle, Natalie, Stellmach, Darryl, Dargan, Paul I.

Volltext